-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G5yqODYx2EEMQL6CvOOdq9Cw6MP8beZMf7GtJuMmQwh+KRAq0V12NLODtuK6+wV4 1NP03gvASsdmT0SDSbkyEw== 0000914190-98-000345.txt : 19980924 0000914190-98-000345.hdr.sgml : 19980924 ACCESSION NUMBER: 0000914190-98-000345 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19980923 ITEM INFORMATION: FILED AS OF DATE: 19980923 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-07707 FILM NUMBER: 98713538 BUSINESS ADDRESS: STREET 1: 7000 CENTRAL AVE NE STREET 2: MS 316 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 6125744000 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 1998 Medtronic, Inc. (Exact name of Registrant as Specified in its Charter) Minnesota (State or Other Jurisdiction of Incorporation) 1-7707 41-0793183 (Commission File Number) (IRS Employer Identification No.) 7000 Central Avenue N.E. Minneapolis, Minnesota 55432-3576 (Address of Principal Executive Offices and Zip Code) (612) 574-4000 (Registrant's telephone number, including area code) Not Applicable (Former Name or Former Address, if Changed Since Last Report) Item 5. Other Events. On September 23, 1998, Medtronic, Inc. closed on its public offering of 12,500,000 shares of Common Stock at a price to the public of $56.75 per share. The net proceeds from the offering of approximately $692 million will be used by Medtronic for general corporate purposes, including acquisitions. The offering was made pursuant to a shelf registration statement filed with the SEC. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDTRONIC, INC. By /s/ Robert L. Ryan Date: September 23, 1998 Robert L. Ryan Senior Vice President and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----